Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 111 - 120 of 1441 shown below

  • Gallina, P

    A Masi, A Becchetti, R Restano-Cassulini, S Polvani, G Hofmann, A M Buccoliero, M Paglierani, B Pollo, G L Taddei, P Gallina, N Di Lorenzo, S Franceschetti, E Wanke and A Arcangeli

    hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines

    advance online publication, 2005-09-20 00:00:00.000;

    doi:10.1038/sj.bjc.6602775

  • Gallinari, F

    S Marchini, M Cirò, F Gallinari, C Geroni, P Cozzi, M D'Incalci and M Broggini

    alpha-Bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity

    doi:10.1038/sj.bjc.6690453

  • Gallinger, S

    M Mrkonjic, E Chappell, V V Pethe, M Manno, D Daftary, C M Greenwood, S Gallinger, B W Zanke, J A Knight and B Bapat

    Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer

    advance online publication, 2009-05-19 00:00:00.000;

    doi:10.1038/sj.bjc.6605097

  • I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger, T Hudson, T Koessler, P D Pharoah, I Niittymäkix, S Tuupanenx, L A Aaltonen, K Hemminki, A Lindblom, A Försti, O Sieber, L Lipton, T van Wezel, H Morreau, J T Wijnen, P Devilee, K Matsuda, Y Nakamura, S Castellví-Bel, C Ruiz-Ponte, A Castells, A Carracedo, J W C Ho, P Sham, R M W Hofstra, P Vodicka, H Brenner, J Hampe, C Schafmayer, J Tepel, S Schreiber, H Völzke, M M Lerch, C A Schmidt, S Buch, V Moreno, C M Villanueva, P Peterlongo, P Radice, M M Echeverry, A Velez, L Carvajal-Carmona, R Scott, S Penegar, P Broderick, A Tenesa and R S Houlston

    COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605338

  • G Liu, P Ghadirian, D Vesprini, N Hamel, A-J Paradis, G Lal, S Gallinger, S A Narod and W D Foulkes

    Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma

    doi:10.1054/bjoc.2000.1221

  • Gallivan, S

    M Kohli, N Ferko, A Martin, E L Franco, D Jenkins, S Gallivan, C Sherlaw-Johnson and M Drummond

    Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK

    advance online publication, 2006-12-05 00:00:00.000;

    doi:10.1038/sj.bjc.6603501

  • Gallo, C

    M Di Maio, F Perrone, C Gallo, R V Iaffaioli, L Manzione, F V Piantedosi, S Cigolari, A Illiano, S Barbera, S F Robbiati, E Piazza, G P Ianniello, L Frontini, E Veltri, F Castiglione, F Rosetti, E De Maio, P Maione and C Gridelli

    Supportive care in patients with advanced non-small-cell lung cancer

    doi:10.1038/sj.bjc.6601236

  • C Gridelli, C Gallo, M Di Maio, E Barletta, A Illiano, P Maione, S Salvagni, F V Piantedosi, G Palazzolo, O Caffo, A Ceribelli, A Falcone, P Mazzanti, L Brancaccio, M A Capuano, L Isa, S Barbera and F Perrone

    A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

    advance online publication, 2004-11-23 00:00:00.000;

    doi:10.1038/sj.bjc.6602241

  • S De Placido, M Lopez, C Carlomagno, G Paoletti, S Palazzo, L Manzione, C Iannace, G P Ianniello, F De Vita, C Ficorella, A Farris, G Pistillucci, M Gemini, E Cortesi, V Adamo, N Gebbia, S Palmeri, C Gallo, F Perrone, G Persico and A R Bianco

    Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study

    advance online publication, 2005-10-11 00:00:00.000;

    doi:10.1038/sj.bjc.6602800

  • C Pacilio, A Morabito, F Nuzzo, A Gravina, V Labonia, G Landi, E Rossi, E De Maio, M Di Maio, G D'aiuto, G Botti, N Normanno, P Chiodini, C Gallo, F Perrone and A de Matteis

    Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

    advance online publication, 2006-04-18 00:00:00.000;

    doi:10.1038/sj.bjc.6603096

  • S Pignata, G Scambia, C Pisano, E Breda, M Di Maio, S Greggi, G Ferrandina, D Lorusso, V Zagonel, A Febbraro, N Riva, V De Rosa, C Gallo and F Perrone

    A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gyneco

    advance online publication, 2007-05-08 00:00:00.000;

    doi:10.1038/sj.bjc.6603787

  • C Gridelli, L Frontini, F Perrone, C Gallo, M Gulisano, S Cigolari, F Castiglione, S F Robbiati, G Gasparini, G P Ianniello, A Farris, M C Locatelli, R Felletti and E Piazza

    Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses

    doi:10.1054/bjoc.2000.1341

  • C Gridelli, L Manzione, F Perrone, E Veltri, R Cioffi, M Grazia Caprio, L Frontini, A Rossi, E Barletta, M L Barzelloni, D Bilancia and C Gallo

    Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study

    doi:10.1054/bjoc.2000.1541

  • Gallo, E

    G Todeschini, S Secchi, E Morra, U Vitolo, E Orlandi, F Pasini, E Gallo, A Ambrosetti, C Tecchio, C Tarella, A Gabbas, A Gallamini, L Gargantini, M Pizzuti, G Fioritoni, L Gottin, G Rossi, M Lazzarino, F Menestrina, M Paulli, M Palestro, M G Cabras, F Di Vito and G Pizzolo

    Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B

    doi:10.1038/sj.bjc.6601460

  • Gallo, F

    P Armaroli, F Gallo, A Bellomi, S Ciatto, D Consonni, D Davi, P Giorgi-Rossi, A Iossa, E Mancini, C Naldoni, E Polla, G Ronco, M Serafini, V Vergini, L Zanier, M Zappa and N Segnan

    Do women greater than or equal to50 years of age need as much screening as women <50 years after they have had negative screening results?

    advance online publication, 2008-07-01 00:00:00.000;

    doi:10.1038/sj.bjc.6604455

  • Gallo, H

    S K Maitra, H Gallo, C Rowland-Payne, D Robinson and H Møller

    Second primary cancers in patients with squamous cell carcinoma of the skin

    advance online publication, 2004-12-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602306

  • Gallo, J

    M E Cianfrocca, K A Kimmel, J Gallo, T Cardoso, M M Brown, G Hudes, N Lewis, L Weiner, G N Lam, S C Brown, D E Shaw, A P Mazar and R B Cohen

    Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

    advance online publication, 2006-05-16 00:00:00.000;

    doi:10.1038/sj.bjc.6603171

  • Gallo, L

    E Baldini, T Prochilo, B Salvadori, A Bolognesi, D Aldrighetti, M Venturini, R Rosso, F Carnino, L Gallo, P Giannessi, P F Conte, C Orlandini and P Bruzzi

    Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

    advance online publication, 2004-06-01 00:00:00.000;

    doi:10.1038/sj.bjc.6601883

  • A Sobrero, A Guglielmi, M Cirillo, E Recaldin, G L Frassineti, C Aschele, A Ravaioli, P Testore, C Caroti, L Gallo, M A Pessi, E Cortesi, D Turci, F Grossi and R Labianca

    5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer

    doi:10.1054/bjoc.2001.1732